Laboratory Reference Grade Compounds

TB-500

RUO In-VitroLyophilized Powder≥99% Reference Standard
Protocol SOP↓
₱2,050.00
Out of stock
Net Content2MG
InclusionAnalytical Lab Set
Volume Discounts:Up to 20% OFF
1
SOPReconstitution Telemetry (2MG)
Diluent:mL
Concentration2.00 mg/mLin 1.0mL BAC
Standard Dose2.5 mg twice weekly (5.0 mg/week total)Syringe: 50.0 units (0.50 mL)
Scale (1 Unit)20 mcgper 0.01 mL (U-100)
• Lyophilized vial onlyMonograph SOP →
TB-5002MG · Analytical Lab Set
₱2,050.00
1
Technical Specification & Protocol Dossier

Analytical Standards & Laboratory Handling

Verified laboratory protocols, reconstitution parameters, and handling guidelines.

P

Pharmacological Profile & Mechanism of Action

Research Monograph

What it is: TB-500 is a synthetic version of the active healing region of Thymosin Beta-4, a naturally occurring protein found in high concentrations in blood platelets and wound fluid.

How it works: Its primary mechanism is actin sequestration—it regulates actin, the essential protein cells use to build their internal skeleton, move, and heal. By upregulating actin, TB-500 accelerates the migration of endothelial cells and fibroblasts to wound sites while calming overactive inflammatory signals like NF-kB.

Why researchers study it: Studied for broad systemic healing, cardiac muscle protection, reducing scar tissue and fibrosis, improving joint flexibility, and repairing skeletal muscle fibers.

Compound & Molecular Specifications

Certificate of Analysis Standards
Target CategoryTissue Repair & Healing
Intended ApplicationLaboratory & In-Vitro Research Only (RUO)
Physical StateLyophilized Solid Powder
CAS Registry Number77591-33-4
PubChem CID45382195↗
Molecular Weight4963.5 g/mol
Purity Specification≥99.0% (HPLC-grade)
Net Content Options2MG, 5MG, 10MG, 20MG
Inclusion PackagesVial Only, Vial + BAC Water, Analytical Lab Set
Peptide Sequence / FormulaFull 44-AA Thymosin Beta-4 Chain (Ac-SDKPDMAEIEKLFDKSKLKKTETQEKNPLPSKETIQQEKQAGES); active fragment Ac-LKKTETQ MW: 887.04 g/mol
⚡ Pharmacodynamic Synergy·Verified Stacking Regimens

Frequently Stacked with TB-500 (Thymosin Beta-4 Frag)

Clinically verified combinations activating complementary physiological pathways without receptor competition.

Stacking Studio
Co-Administered Regimen

BPC-157 Arginate (Stable Oral/SubQ)

+99 Synergy
Enhanced Wolverine Stack: Acid-Stable Angiogenesis + Systemic Actin Remodeling

Stable L-arginate salt of BPC-157 ensures robust microvascular VEGFR2 capillary ingrowth and gut barrier recovery, perfectly paired with TB-500 systemic G-actin sequestration for organized scar-free tissue repair.

⏱BPC-157 Arginate: 250–500 mcg daily (SubQ or oral)•🛡Separate syringe
15% Off bundle
Compare
Co-Administered Regimen

BPC-157 (Pentadecapeptide)

+98 Synergy
The Wolverine Stack: Dual Microvascular & Actin Remodeling Synergy

BPC-157 acts locally by accelerating microvascular angiogenesis via VEGFR2 and stabilizing granulation tissue, while TB-500 sequesters G-actin to drive rapid systemic cell migration and prevent fibrous adhesion/scar formation.

⏱In-vitro assay titration protocol•🛡Separate syringe
15% Off bundle
Compare